← Leaderboards
Paul R Knight
State University Of New York At Buffalo
$9,756,445
Attributed
$9,756,445
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $792.4K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$9,756,445 · 5
By mechanism
R01$7,177,732 · 3
T32$1,797,219 · 1
R21$781,494 · 1
Top collaborators
No co-investigators on record.
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Robert M Straubinger$4,875,752
- Alexis Cassandra Thompson$1,720,360
- Jun Qu$2,101,366
- Krishnan Chakravarthy$395,442
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineBacterial PneumoniaResponseInflammatoryEpithelial CellsSeveritiesMorbidity - Disease RateCellsInfluenzaLung InjuryMonocyte Chemoattractant Protein 1Alveolar MacrophagesEtiologyMacrophage Inflammatory ProteinsPathogenesisDesignPharmaceutical PreparationsNeutrophilParticlePneumoniaResearch TrainingTraining ProgramsAnesthesiologyMortality Vital Statistics
Grant awards (31)
Immunotherapy for acute lung injury secondary to influenza$436,772
R01 · FY2023 · HL · contact PI
Immunotherapy for acute lung injury secondary to influenza$436,772
R01 · FY2022 · HL · contact PI
Immunotherapy for acute lung injury secondary to influenza$436,772
R01 · FY2021 · HL · contact PI
Anesthesiology Research Training Program$1
T32 · FY2021 · GM · contact PI
Immunotherapy for acute lung injury secondary to influenza$436,772
R01 · FY2020 · HL · contact PI
Anesthesiology Research Training Program$234,637
T32 · FY2020 · GM · contact PI
Anesthesiology Research Training Program$217,919
T32 · FY2019 · GM · contact PI
Anesthesiology Research Training Program$216,610
T32 · FY2018 · GM · contact PI
Anesthesiology Research Training Program$212,281
T32 · FY2017 · GM · contact PI
Anesthesiology Research Training Program$202,895
T32 · FY2016 · GM · contact PI
Anesthesiology Research Training Program$194,355
T32 · FY2015 · GM · contact PI
Anesthesiology Research Training Program$197,206
T32 · FY2014 · GM · contact PI
Anesthesiology Research Training Program$194,588
T32 · FY2013 · GM · contact PI
Anesthesiology Research Training Program$126,727
T32 · FY2012 · GM · contact PI
Pathogenesis of Aspiration Pneumonitis$396,250
R01 · FY2011 · HL · contact PI
Pathogenesis of Aspiration Pneumonitis$396,250
R01 · FY2010 · HL · contact PI
Influenza therapy by Au-nanorod 5'PPP-NS1-siRNA/cDNA targeting of bronchial cells$396,117
R21 · FY2010 · AI · contact PI
Pathogenesis of Aspiration Pneumonitis$396,250
R01 · FY2009 · HL · contact PI
Influenza therapy by Au-nanorod 5'PPP-NS1-siRNA/cDNA targeting of bronchial cells$385,377
R21 · FY2009 · AI · contact PI
Pathogenesis of Aspiration Pneumonitis$396,250
R01 · FY2008 · HL · contact PI
Pathogenesis of Aspiration Pneumonitis$396,250
R01 · FY2007 · HL · contact PI
Host response to post-operative pneumonia$392,500
R01 · FY2005 · AI
Host response to post-operative pneumonia$486,318
R01 · FY2004 · AI
Host response to post-operative pneumonia$483,585
R01 · FY2003 · AI
PATHOGENESIS OF ASPIRATION PNEUMONITIS$309,257
R01 · FY2003 · HL
Host response to post-operative pneumonia$390,000
R01 · FY2002 · AI
PATHOGENESIS OF ASPIRATION PNEUMONITIS$309,257
R01 · FY2002 · HL
Host response to post-operative pneumonia$81,326
R01 · FY2002 · AI
Host response to post-operative pneumonia$365,137
R01 · FY2001 · AI
PATHOGENESIS OF ASPIRATION PNEUMONITIS$309,257
R01 · FY2001 · HL
PATHOGENESIS OF ASPIRATION PNEUMONITIS$322,757
R01 · FY2000 · HL